CN1051926C - Anti-cancer Chinese drug-Xiaoliujing capsule - Google Patents
Anti-cancer Chinese drug-Xiaoliujing capsule Download PDFInfo
- Publication number
- CN1051926C CN1051926C CN94110281A CN94110281A CN1051926C CN 1051926 C CN1051926 C CN 1051926C CN 94110281 A CN94110281 A CN 94110281A CN 94110281 A CN94110281 A CN 94110281A CN 1051926 C CN1051926 C CN 1051926C
- Authority
- CN
- China
- Prior art keywords
- capsule
- radix
- chinese
- chinese herbal
- xiaoliujing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention relates to a Chinese herbal medicine for preventing cancer, namely Xiaoliujing capsule. The capsule is composed of Chinese herbal medicines of american ginseng, leech, corydalis tuber, notoginseng, angelica, curcuma aromatica salisb, Chinese stellera root, rabdosia, olibanum, myrrh, toad venom, hairy deer-horn(hairy antler), lightyellow sophora root, coptis, stiff silkorm and Chinese caterpillar fungus; the Chinese herbal medicines are processed and powdered into fine powder, are uniformly mixed, are filtered by a sieve of number zero, and are placed in the capsule of number zero in an aseptic condition. The present invention has the advantages of convenient taking, long storage period and obvious anticancer effect; in the pharmacological test, the average inhibition ratios for three groups of mouse transplantation tumour S180 and EAC entity types of high dosage and low dosage are respectively 66.8%, 45.9%, 52.2% and 44.9%, and the ratios exceeds the effective standard of 30%.
Description
The present invention relates to a kind of Chinese medicine preparation, particularly a kind of anticancer Chinese medicinal capsule preparation.
Existing Chinese medicine medicine for preventing preparation has decoction, powder etc., takes very inconveniently, and effect is also not really desirable, for decoction, can destroy active ingredient when boiling, and after being boiled into, storage period is short, boil trouble, and bitter in the mouth, amount be big, be difficult for accepting.
The objective of the invention is in order to overcome above-mentioned deficiency, propose that a kind of therapeutic effect is good, the anticancer capsule preparation of taking convenience.
The present invention is achieved using the following method.
Capsular Chinese medicine composition of this Chinese medicine medicine for preventing and content are as follows:
Radix Panacis Quinquefolii 217-237g Hirudo 126-146g
Rhizoma Corydalis 217-237g Radix Notoginseng 126-146g
Radix Angelicae Sinensis 217-237g temperature Rhizoma Curcumae 217-237g
Stellera chamaejasme L. 85-105g Rabdosia rubescens 217-237g
Olibanum 81-101g Myrrha 81-101g
Venenum Bufonis 126-146g Cornu Cervi Pantotrichum 217-237g
Radix Sophorae Flavescentis 217-237g Rhizoma Coptidis 217-237g
Bombyx Batryticatus 262-282g Cordyceps 217-237g
The Chinese medicine of above-mentioned composition and content, processing powder is broken into fine powder, and mix homogeneously is crossed No. 6 and sieved three times, under aseptic condition, incapsulates.
Shenyang Pharmacy College's Pharmacology Lab has been made animal experiment with white mice to the present invention, and has proposed " probation report of the clean antitumor action of dispersing tumor ", and report is pointed out: the present invention is to white mice transplanted tumor S
180With the EAC solid type obvious antitumor action is arranged all, test has better repeatability and dose-effect relationship, to S
180Three batches of average suppression ratio of high and low two dosage groups are respectively 66.8% and 45.9% (P＜0.01); To three batches of average suppression ratio of EAC entity, high dose is 52.2% (P＜0.01), and low dosage is 44.9% (P＜0.01), all above effective standard of 30%, illustrates that the present invention is to S
180With the EAC solid type stronger antitumor action is arranged all.
Toxic and side effects taking convenience, storage period is grown, do not have to Chinese medicine preparation of the present invention.
Embodiment: capsular Chinese medicine composition of this Chinese medicine medicine for preventing and content are as follows:
Radix Panacis Quinquefolii 227g Hirudo 136g
Rhizoma Corydalis 227g Radix Notoginseng 136g
Radix Angelicae Sinensis 227g temperature Rhizoma Curcumae 227g
Stellera chamaejasme L. 95g Rabdosia rubescens 227g
Olibanum 91g Myrrha 91g
Venenum Bufonis 136g Cornu Cervi Pantotrichum 227g
Radix Sophorae Flavescentis 227g Rhizoma Coptidis 227g
Bombyx Batryticatus 272g Cordyceps 227g
Method for making: it is an amount of to get Cornu Cervi Pantotrichum, burns remove floss, and scraping is split into fragment, is ground into fine powder, take by weighing 227 the gram standby.In addition with an amount of Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae) and Venenum Bufonis respectively processing powder be broken into fine powder, it is standby to take by weighing recipe quantity.Take by weighing other medical material of respectively distinguishing the flavor of of above-mentioned recipe quantity after the processing and mix and pulverize, add Pulveratum Cornu Cervi Pantotrichum, Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae) powder, Venenum Bufonis powder, mix homogeneously is crossed No. 6 sieves three times.Under aseptic condition, adorn 10,000 of No. 0 capsules.
Claims (2)
1. a Chinese medicine medicine for preventing capsule adopts medicament in the capsulation powdery, and it is characterized in that: the composition and the content of the middle medicament of 10,000 capsules are:
Radix Panacis Quinquefolii 217-237g Hirudo 126-146g
Rhizoma Corydalis 217-237g Radix Notoginseng 126-146g
Radix Angelicae Sinensis 217-237g temperature Rhizoma Curcumae 217-237g
Stellera chamaejasme L. 85-105g Rabdosia rubescens 217-237g
Olibanum 81-101g Myrrha 81-101g
Venenum Bufonis 126-146g Cornu Cervi Pantotrichum 217-237g
Radix Sophorae Flavescentis 217-237g Rhizoma Coptidis 217-237g
Bombyx Batryticatus 262-282g Cordyceps 217-237g
2. by the described Chinese medicine medicine for preventing capsule of claim 1, it is characterized in that: the composition and the content of medicament are in described:
Radix Panacis Quinquefolii 227g Hirudo 136g
Rhizoma Corydalis 227g Radix Notoginseng 136g
Radix Angelicae Sinensis 227g temperature Rhizoma Curcumae 227g
Stellera chamaejasme L. 95g Rabdosia rubescens 227g
Olibanum 91g Myrrha 91g
Venenum Bufonis 136g Cornu Cervi Pantotrichum 227g
Radix Sophorae Flavescentis 227g Rhizoma Coptidis 227g
Bombyx Batryticatus 272g Cordyceps 227g
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94110281A CN1051926C (en) | 1994-05-27 | 1994-05-27 | Anti-cancer Chinese drug-Xiaoliujing capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94110281A CN1051926C (en) | 1994-05-27 | 1994-05-27 | Anti-cancer Chinese drug-Xiaoliujing capsule |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1113790A CN1113790A (en) | 1995-12-27 |
| CN1051926C true CN1051926C (en) | 2000-05-03 |
Family
ID=5034261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN94110281A Expired - Fee Related CN1051926C (en) | 1994-05-27 | 1994-05-27 | Anti-cancer Chinese drug-Xiaoliujing capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1051926C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100239879B1 (en) * | 1997-11-05 | 2000-02-01 | 김상조 | Crude drug composition for treatment and prevention of liver cancer |
| CN101450145B (en) * | 2008-12-23 | 2010-12-15 | 朱友文 | Traditional Chinese medicine for treating malignancy and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1057399A (en) * | 1990-06-18 | 1992-01-01 | 李文升 | A kind of manufacture method of Chinese medicine atomic powder for clearing lump in abdomen |
| CN1085093A (en) * | 1993-06-14 | 1994-04-13 | 沈庆新 | The prescription of cancer eliminating pill and production technology |
-
1994
- 1994-05-27 CN CN94110281A patent/CN1051926C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1057399A (en) * | 1990-06-18 | 1992-01-01 | 李文升 | A kind of manufacture method of Chinese medicine atomic powder for clearing lump in abdomen |
| CN1085093A (en) * | 1993-06-14 | 1994-04-13 | 沈庆新 | The prescription of cancer eliminating pill and production technology |
Non-Patent Citations (4)
| Title |
|---|
| 《中西医结合杂志》4(9) 1984.9.30 杨宝印等 30组中药复方动物抑瘤实验观察 * |
| 《北京中医》(1) 1994.1.31 杨炳初 平萎消异汤治疗79例胃癌前病变的疗效分析 * |
| 《北京中医》(1) 1994.1.31 杨炳初 平萎消异汤治疗79例胃癌前病变的疗效分析;《天津中医》(3) 1992.3.31 苗厚润等 以中药为不治疗晚期卵巢癌44例临闲观察;《中西医结合杂志》4(9) 1984.9.30 杨宝印等 30组中药复方动物抑瘤实验观察 * |
| 《天津中医》(3) 1992.3.31 苗厚润等 以中药为不治疗晚期卵巢癌44例临闲观察 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1113790A (en) | 1995-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20040043092A (en) | Novel medicinal herbal composition for treating liver diseases and hiv | |
| JP2004161732A (en) | Natural medicine preparation for treatment of hiv/aids patient | |
| CN105535448B (en) | Traditional Chinese medicine composition for treating children myasthenia gravis | |
| CN1051008C (en) | Chinese medicine composite for coronary heart disease and angina | |
| CN1051926C (en) | Anti-cancer Chinese drug-Xiaoliujing capsule | |
| CN1069530C (en) | Instant powder for nourishing blood and its prepn. method | |
| CN1736449A (en) | Powder for climacteric syndrome and its preparing process | |
| CN1176113A (en) | Compound bufonin of bufo gargarizans | |
| CN1234408C (en) | Compound Sanhuang powder | |
| CN101028319B (en) | Chinese-medicine compound preparation against coronary heart disease and its production | |
| CN115969903B (en) | Traditional Chinese medicine composition, preparation method thereof and application of traditional Chinese medicine composition in preparation of medicines with fatty liver prevention and treatment effects | |
| CN1698708A (en) | Leucorrhea disease treatment capsule and its preparation method | |
| CN1094624A (en) | Quick-acting fat-lowering spirit Chinese medicine | |
| CN1059117C (en) | Katsutoxin pill for tumor and preparing method thereof | |
| CN1217204A (en) | Medicine for nourishing muscle and recovering physical strength, and preparation method therefor | |
| CN1733206A (en) | Chinese traditional medicine preparation for curing mastoplasia | |
| CN1060663C (en) | Compound Tibet capillary artemisia patent medicine | |
| CN1092055C (en) | Chinese medicine preparation | |
| CN113197947B (en) | Composition for clearing and activating channels and collaterals and dredging blood vessels and preparation method thereof | |
| CN1107350A (en) | "Changhualing" No.1 for treatment of colitis and its preparing process | |
| CN1058410C (en) | Traditional Chinese medicine preparation for curing liver-gallbladder disease | |
| CN1108943A (en) | Medicine "Yigankang" for hepatitis B and its preparation | |
| CN1943677A (en) | A Chinese traditional medicinal composition and its preparation method | |
| CN1056759C (en) | Traditional Chinese medicine preparation for prevention and treatment of hepatitis B | |
| CN1739729A (en) | Xiaokeling prepn for treating diabetes and its prepn process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |